EXOSF Stock Chart & Stats
$51.55
$0.00(0.00%)
At close: 4:00 PM EDT
$51.55
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$51.55 - $51.55
Previous CloseN/A
Volume15.00
Average Volume (3M)13.00
Market Cap
$3.29B
Enterprise Value$3.08B
Total Cash (Recent Filing)$105.20M
Total Debt (Recent Filing)$269.50M
Price to Earnings (P/E)97.4
Beta0.00
Next Earnings
Feb 22, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.59
Shares Outstanding50,936,750
10 Day Avg. Volume40
30 Day Avg. Volume13
Financial Highlights & Ratios
PEG Ratio1.44
Price to Book (P/B)5.54
Price to Sales (P/S)5.27
P/FCF Ratio50.88
Enterprise Value/Market Cap0.94
Enterprise Value/Revenue6.20
Enterprise Value/Gross Profit35.59
Enterprise Value/Ebitda20.21
Forecast
1Y Price Target
$79.28Price Target Upside53.80% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)2.08
Revenue Forecast (FY)$628.91M
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthA sustained multi-year revenue expansion indicates recurring demand for Exosens’s optoelectronic and imaging offerings. Continued growth broadens the operating base, supports investment in product capabilities, and provides a durable foundation for future earnings progression.
Profitability TurnaroundThe shift from earlier losses to sustained profitability demonstrates meaningful operational improvement and a stronger earnings model. Solid recent EBITDA margins suggest the business can convert revenue into operating profit, supporting reinvestment and financial resilience.
Material DeleveragingSubstantial deleveraging has strengthened Exosens’s balance sheet and reduced the financial burden relative to its equity base. Greater balance-sheet flexibility can support investment, improve resilience through procurement cycles, and reduce constraints on capital allocation.
Bears Say
Sharp Gross-margin CompressionThe steep gross-margin decline raises questions about the durability of Exosens’s profitability, whether driven by mix, pricing, or costs. If the lower margin persists, it could reduce operating leverage and limit how much revenue growth translates into earnings.
Volatile Free-cash-flow ConversionAlthough cash generation remains positive, the weaker 2025 conversion shows that earnings are not consistently translating into available cash. Persistent reinvestment or working-capital demands could reduce funding flexibility and make internally financed growth less predictable.
Remaining Debt And Moderate ReturnsThe balance sheet is improved but still carries meaningful absolute debt, while returns on equity remain moderate rather than strong. This combination can limit financial flexibility and leaves less room for underperformance if operating conditions weaken.
Exosens News
EXOSF FAQ
What was Exosens’s price range in the past 12 months?
Exosens lowest stock price was $51.55 and its highest was $51.55 in the past 12 months.
What is Exosens’s market cap?
Exosens’s market cap is $3.29B.
When is Exosens’s upcoming earnings report date?
Exosens’s upcoming earnings report date is Feb 22, 2027 which is in 124 days.
How were Exosens’s earnings last quarter?
Exosens released its earnings results on Jul 28, 2026. The company reported $0.349 earnings per share for the quarter.
Is Exosens overvalued?
According to Wall Street analysts Exosens’s price is currently Undervalued.
Does Exosens pay dividends?
Exosens does not currently pay dividends.
What is Exosens’s EPS estimate?
Exosens’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Exosens have?
Exosens has 50,936,750 shares outstanding.
What happened to Exosens’s price movement after its last earnings report?
Exosens reported an EPS of $0.349 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Exosens?
Currently, no hedge funds are holding shares in EXOSF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Exosens
Exosens specializes in the development, production, and global distribution of advanced electro-optical technologies. Its core expertise lies in amplification, detection, and imaging solutions, catering to markets across France, the rest of Europe, North America, Asia, Oceania, and Africa, as well as other international territories. The company's extensive product portfolio features image intensifier tubes; a diverse array of cameras covering ultraviolet, short-wave, long-wave, visible-near infrared, and mid-wave infrared spectra; and enhanced vision equipment. Exosens further provides ion, electron, scintillation, and single photon detection products; X-ray components, neutronic imaging systems, and image intensifiers tailored for scientific applications; alongside gamma and neutron detectors, and mineral insulated extensions. Additionally, it supplies power tubes, microwave devices, and airborne solutions for methane detection. Operating under prominent brands including Photonis, Xenics, Telops, and El-Mul, Exosens serves vital sectors such as defense and surveillance, industrial research and control, life science and environmental monitoring, and the nuclear industry. Established in 1937 and headquartered in Mérignac, France, Exosens functions as a subsidiary of HLD Europe S.C.A.
EXOSF Stock 12 Month Forecast
Average Price Target
$79.28
▲(53.80% Upside)
Technical Analysis
Ownership Overview
―
Insiders
5.04% Mutual Funds
― Other Institutional Investors
87.47% Public Companies and
Individual Investors